In vivo characterization of renal auto‐antigens involved in human auto‐immune diseases: The case of membranous glomerulonephritis
- 3 December 2010
- journal article
- review article
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 5 (1-2) , 90-97
Abstract
Renal auto‐immune diseases represent a major source of morbidity in humans. For many years the knowledge on mechanisms of auto‐immunity involving the kidney has been uniquely based on animal models. However, these findings often could not be readily translated to humans owing to notably difference in antigen expression by human podocytes. One example is Heymann nephritis (HN), the experimental model of human membranous glomerulonephritis (MGN), which is obtained in rats by injecting antibodies against megalin, a protein that is not present in human glomeruli. Human studies could not be done in the past since sequencing required too much material exceeding what obtainable from tissue biopsies in vivo. Research is now on the way to identify auto‐antigens and isolate specific auto‐antibodies in humans. New technology developments based on tissue microdissection and proteomical analysis have facilitated the recent discoveries, allowing direct analysis of human tissue in vivo. Major advances on the pathogenesis of MGN, the prototype for the formation and glomerular deposition of auto‐antibodies, are now in progress. Two independent groups have, in fact, demonstrated the existence of specific IgG4 against phospholipase A2 receptor, aldose reductase and Mn‐superoxide dismutase in glomerular eluates and in plasma of a prominent part of patients with MGN, suggesting a major role of these proteins as auto‐antigens in human MGN. This review will focalize these aspects outlining the contribution of proteomics in most recent developments.Keywords
This publication has 31 references indexed in Scilit:
- Autoimmunity in Membranous Nephropathy Targets Aldose Reductase and SOD2Journal of the American Society of Nephrology, 2010
- Pathogenesis of kidney disease in systemic lupus erythematosusCurrent Opinion in Rheumatology, 2009
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous NephropathyNew England Journal of Medicine, 2009
- Chronic hypoxia aggravates renal injury via suppression of Cu/Zn-SOD: a proteomic analysisAmerican Journal of Physiology-Renal Physiology, 2008
- Glomerular clusterin is associated with PKC-α/β regulation and good outcome of membranous glomerulonephritis in humansKidney International, 2006
- New target antigens for antiendothelial cell antibodiesImmunobiology, 2005
- Developmental expression and function of aldehyde reductase in proximal tubules of the kidneyAmerican Journal of Physiology-Renal Physiology, 2005
- Pathomechanisms and molecular basis of membranous glomerulopathyThe Lancet, 2004
- Soft immobilized pH gradient gels in proteome analysis: A follow‐upProteomics, 2003
- Controlled Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous NephropathyNew England Journal of Medicine, 1984